These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14582439)

  • 61. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 62. COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with heart failure.
    Greenberg BH; Mehra M; Teerlink JR; Ordronneau P; McCollum D; Gilbert EM
    Am J Cardiol; 2006 Oct; 98(7A):53L-59L. PubMed ID: 17023233
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A comment on COMET: how to interpret a positive trial?
    Massie BM
    J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781
    [No Abstract]   [Full Text] [Related]  

  • 64. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute hemodynamic effects of moderate doses of nebivolol versus metoprolol in patients with systolic heart failure.
    Triposkiadis F; Giamouzis G; Kelepeshis G; Sitafidis G; Skoularigis J; Demopoulos V
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):71-7. PubMed ID: 17323786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.
    Albert NM
    Crit Care Nurse; 2007 Dec; 27(6):62-72. PubMed ID: 18032686
    [No Abstract]   [Full Text] [Related]  

  • 67. A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
    Jonsson G; Abdelnoor M; Müller C; Kjeldsen SE; Os I; Westheim A
    Cardiology; 2005; 103(3):148-55. PubMed ID: 15785019
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.
    Weber K; Bohmeke T; van der Does R; Taylor SH
    Am J Hypertens; 1998 May; 11(5):614-7. PubMed ID: 9633801
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of carvedilol in heart failure due to dilated cardiomyopathy. Results of a double-blind randomized placebo-controlled study (CARIBE study).
    Chizzola PR; Freitas HF; Caldas MA; da Costa JM; Meneghetti C; Marinho NV; Mansur AJ; Ramires JA; Bocchi EA
    Arq Bras Cardiol; 2000 Mar; 74(3):233-42. PubMed ID: 10951826
    [TBL] [Abstract][Full Text] [Related]  

  • 70. β-Blockers in diabetic patients with heart failure.
    Santulli G
    JAMA Intern Med; 2015 Apr; 175(4):657. PubMed ID: 25844751
    [No Abstract]   [Full Text] [Related]  

  • 71. β-Blockers in diabetic patients with heart failure--reply.
    Pasternak B; Svanström H; Hviid A
    JAMA Intern Med; 2015 Apr; 175(4):657. PubMed ID: 25844752
    [No Abstract]   [Full Text] [Related]  

  • 72. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
    Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
    [No Abstract]   [Full Text] [Related]  

  • 73. [Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction].
    Ruta J; Ptaszyński P; Maciejewski M; Goch JH; Chizyński K
    Wiad Lek; 2006; 59(9-10):649-53. PubMed ID: 17338123
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.
    De Freitas O; Lenz O; Fornoni A; Materson BJ
    Vasc Health Risk Manag; 2006; 2(2):139-44. PubMed ID: 17319457
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.
    Zendaoui A; Lachance D; Roussel E; Couet J; Arsenault M
    Circ Heart Fail; 2011 Mar; 4(2):207-13. PubMed ID: 21216836
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of metoprolol with low, middle and high doses of carvedilol in prevention of postinfarction left ventricular remodeling in rats.
    Yang Y; Tang Y; Ruan Y; Wang Y; Gao R; Chen J; Chen Z
    Jpn Heart J; 2003 Nov; 44(6):979-88. PubMed ID: 14711192
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mapping the journey.
    Stevenson LW; Lewis E
    J Am Coll Cardiol; 2006 Apr; 47(8):1612-4. PubMed ID: 16630998
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.
    Maggioni AP; Sinagra G; Opasich C; Geraci E; Gorini M; Gronda E; Lucci D; Tognoni G; Balli E; Tavazzi L;
    Heart; 2003 Mar; 89(3):299-305. PubMed ID: 12591836
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of the effects of metoprolol or carvedilol on serum gamma-glutamyltransferase and uric acid levels among patients with acute coronary syndrome without ST segment elevation.
    Aşkın L; Karakelleoğlu Ş; Değirmenci H; Demirelli S; Şimşek Z; Taş MH; Topçu S; Lazoğlu Z
    Anatol J Cardiol; 2016 Jan; 16(1):16-22. PubMed ID: 26467358
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Role of beta-blockers in the treatment of chronic heart heart failure].
    Czuriga I; Edes I
    Orv Hetil; 2001 Sep; 142(37):2005-12. PubMed ID: 11582731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.